High detection rate in [18F]PSMA-1007 PET: interim results focusing on biochemical recurrence in prostate cancer patients

18F-labeled prostate-specific membrane antigen (PSMA) ligand, [18F]PSMA-1007, has the benefit of a higher synthetic yield and minimal excretion in the urine. High detection efficacy was reported in biochemical recurrence (BCR) of prostate cancer after radical prostatectomy. Thus, we evaluated the pr...

Full description

Bibliographic Details

Main Authors:	Watabe, Tadashi (Author) , Uemura, Motohide (Author) , Soeda, Fumihiko (Author) , Naka, Sadahiro (Author) , Ujike, Takeshi (Author) , Hatano, Koji (Author) , Sasaki, Hidetaka (Author) , Kamiya, Takashi (Author) , Shimosegawa, Eku (Author) , Kato, Hiroki (Author) , Cardinale, Jens (Author) , Tateishi, Ukihide (Author) , Nonomura, Norio (Author) , Giesel, Frederik L. (Author)
Format:	Article (Journal)
Language:	English
Published:	04 March 2021
In:	Annals of nuclear medicine Year: 2021, Volume: 35, Issue: 4, Pages: 523-528
ISSN:	1864-6433
DOI:	10.1007/s12149-021-01602-x
Online Access:	Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1007/s12149-021-01602-x
Author Notes:	Tadashi Watabe, Motohide Uemura, Fumihiko Soeda, Sadahiro Naka, Takeshi Ujike, Koji Hatano, Hidetaka Sasaki, Takashi Kamiya, Eku Shimosegawa, Hiroki Kato, Jens Cardinale, Ukihide Tateishi, Norio Nonomura, Frederik L. Giesel